However, in SuHx animals, CXCR4 inhibition only caused a modest reduction in PAH and did not significantly decrease the number of c-kit+ vWF+ or proliferating c-kit+ vWF+ cells in pulmonary arteries. Here, CXCR4 is linked to pulmonary arterial hypertension.